1. A Novel CYP2C‐Haplotype Associated With Ultrarapid Metabolism of Escitalopram. Issue 3 (13th April 2021) Authors: Bråten, Line Skute; Haslemo, Tore; Jukic, Marin M.; Ivanov, Maxim; Ingelman‐Sundberg, Magnus; Molden, Espen; Kringen, Marianne Kristiansen Journal: Clinical pharmacology & therapeutics Issue: Volume 110:Issue 3(2021) Page Start: 786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association Between CYP2D6 Metabolizer Status and Vortioxetine Exposure and Treatment Switching: A Retrospective, Naturalistic Cohort Study Using Therapeutic Drug Monitoring Data From 640 Patients. Issue 4 (13th July 2022) Authors: Frederiksen, Trine; Smith, Robert L.; Jukic, Marin M.; Molden, Espen Journal: Journal of clinical psychopharmacology Issue: Volume 42:Issue 4(2022) Page Start: 396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population. Issue 9 (22nd June 2022) Authors: Bråten, Line Skute; Ingelman‐Sundberg, Magnus; Jukic, Marin M.; Molden, Espen; Kringen, Marianne Kristiansen Journal: Clinical and translational science Issue: Volume 15:Issue 9(2022) Page Start: 2135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗